Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093060745> ?p ?o ?g. }
- W2093060745 endingPage "115" @default.
- W2093060745 startingPage "100" @default.
- W2093060745 abstract "Despite great advances in our understanding of the driving events involved in malignant transformation, only a small number of oncogenic drivers have been targeted and translated into tangible clinical benefit. Moreover, even when a targeted therapy can be shown to effectively inhibit an oncogenic driver, leading to cancer remission, disease persistence and/or relapse is typically inevitable. Reemergence of the cancer can result from either intrinsic or acquired resistance mechanisms that result in failure to eliminate all cancer cells. Intrinsic mechanisms of resistance include tumor heterogeneity and pathways that can compensate for the inhibition of the oncogenic driver. Acquired resistance mechanisms include mutation of the oncogenic driver to directly prevent drug-mediated inhibition and the activation of compensatory survival pathways. RNA interference (RNAi)-based screening provides a powerful approach for the interrogation of both intrinsic and acquired resistance mechanisms. The availability of short interfering (si)RNA libraries targeting all human and mouse genes has made it possible to perform large-scale unbiased screens to identify pathways that are specifically required in cancer cells of particular genotypes or following particular treatments, facilitating the design of potential new therapeutic strategies that may limit resistance mechanisms. In this review, we will discuss how RNAi screens can be used to uncover critical growth and survival pathways and aid in the identification of novel therapeutic targets for improved treatment of hematological malignancies." @default.
- W2093060745 created "2016-06-24" @default.
- W2093060745 creator A5034184119 @default.
- W2093060745 creator A5042314711 @default.
- W2093060745 creator A5069000114 @default.
- W2093060745 date "2012-09-01" @default.
- W2093060745 modified "2023-09-24" @default.
- W2093060745 title "Using functional genomics to overcome therapeutic resistance in hematological malignancies" @default.
- W2093060745 cites W120419820 @default.
- W2093060745 cites W1554600230 @default.
- W2093060745 cites W1755870104 @default.
- W2093060745 cites W1965440903 @default.
- W2093060745 cites W1967920366 @default.
- W2093060745 cites W1968904120 @default.
- W2093060745 cites W1969228079 @default.
- W2093060745 cites W1970135399 @default.
- W2093060745 cites W1975301877 @default.
- W2093060745 cites W1975975368 @default.
- W2093060745 cites W1976058906 @default.
- W2093060745 cites W1976402300 @default.
- W2093060745 cites W1981415835 @default.
- W2093060745 cites W1984352048 @default.
- W2093060745 cites W1984863053 @default.
- W2093060745 cites W1984879354 @default.
- W2093060745 cites W1985264867 @default.
- W2093060745 cites W1987239635 @default.
- W2093060745 cites W1988228415 @default.
- W2093060745 cites W1989891384 @default.
- W2093060745 cites W1992320631 @default.
- W2093060745 cites W1992842669 @default.
- W2093060745 cites W1993501781 @default.
- W2093060745 cites W1998971866 @default.
- W2093060745 cites W1999614615 @default.
- W2093060745 cites W2003984225 @default.
- W2093060745 cites W2006308301 @default.
- W2093060745 cites W2008271309 @default.
- W2093060745 cites W2008836121 @default.
- W2093060745 cites W2009931781 @default.
- W2093060745 cites W2011853681 @default.
- W2093060745 cites W2013356610 @default.
- W2093060745 cites W2013477475 @default.
- W2093060745 cites W2013689460 @default.
- W2093060745 cites W2014623749 @default.
- W2093060745 cites W2016246269 @default.
- W2093060745 cites W2016656445 @default.
- W2093060745 cites W2017187984 @default.
- W2093060745 cites W2018518082 @default.
- W2093060745 cites W2021648831 @default.
- W2093060745 cites W2022899908 @default.
- W2093060745 cites W2024235347 @default.
- W2093060745 cites W2027638186 @default.
- W2093060745 cites W2031594339 @default.
- W2093060745 cites W2032211985 @default.
- W2093060745 cites W2035151737 @default.
- W2093060745 cites W2036062404 @default.
- W2093060745 cites W2036281060 @default.
- W2093060745 cites W2041636661 @default.
- W2093060745 cites W2045399297 @default.
- W2093060745 cites W2051000382 @default.
- W2093060745 cites W2051890772 @default.
- W2093060745 cites W2055001622 @default.
- W2093060745 cites W2059357290 @default.
- W2093060745 cites W2062010938 @default.
- W2093060745 cites W2065851457 @default.
- W2093060745 cites W2068962767 @default.
- W2093060745 cites W2069444276 @default.
- W2093060745 cites W2074198797 @default.
- W2093060745 cites W2074410038 @default.
- W2093060745 cites W2074740555 @default.
- W2093060745 cites W2076500257 @default.
- W2093060745 cites W2076680628 @default.
- W2093060745 cites W2076858918 @default.
- W2093060745 cites W2077813812 @default.
- W2093060745 cites W2078786399 @default.
- W2093060745 cites W2078972833 @default.
- W2093060745 cites W2079296353 @default.
- W2093060745 cites W2086721777 @default.
- W2093060745 cites W2086858024 @default.
- W2093060745 cites W2087955215 @default.
- W2093060745 cites W2088594243 @default.
- W2093060745 cites W2090029719 @default.
- W2093060745 cites W2091423586 @default.
- W2093060745 cites W2091999960 @default.
- W2093060745 cites W2092880883 @default.
- W2093060745 cites W2093144236 @default.
- W2093060745 cites W2093334071 @default.
- W2093060745 cites W2093613683 @default.
- W2093060745 cites W2094069182 @default.
- W2093060745 cites W2096156234 @default.
- W2093060745 cites W2096336184 @default.
- W2093060745 cites W2098455835 @default.
- W2093060745 cites W2099505694 @default.
- W2093060745 cites W2101322783 @default.
- W2093060745 cites W2104324375 @default.
- W2093060745 cites W2106082819 @default.
- W2093060745 cites W2106391833 @default.
- W2093060745 cites W2107398329 @default.
- W2093060745 cites W2108145697 @default.